Sanford School of Medicine Basic Biomedical Sciences

Khosrow Rezvani, Ph.D.

Khosrow Rezvani
Assistant Professor
Medicine: Basic Biomedical Sciences, Health Affairs
UMS Lee Med/Sanford School of Medicine 345
Phone: 605-677-6898
Teaching Interests:
Biochemistry, Molecular Biology and Cancer Biology
Research Interests:
The role of Ubiquitin-proteasome pathway in cancer
Education:
  • Ph D, Molecular and Cell Biology, University of Nottingham, 2002
  • MD, Medical doctor, University of Kashan, Medical school, 1998
Publications:
  • Dong, G., Ferguson, J. M., Duling, A. J., Nicolas, R. G., Zhang, D., Rezvani, K., Fang, S., Monterio, M. J., Li, S., Li, X. J., Wang, H., (2011), Modeling Pathogenesis of Huntington’s Disease with Inducible Neuroprogenitor Cells, Cell Mol Neurobiol , vol. 31, p. 737.
Awards and Honors:
  • Reviwer, International Journal of Medical Sciences , 2012
  • Reviwer, Biochemical Pharmacology , 2012
  • Editor, The International journal of bioinorganic hybrid nanomaterial , 2011
Presentations:
  • Pattison, J. S., Rezvani, K. Defining the Role of p62 on Protein Degradation Processes and Heart Failure. Presented at the 3rd Floor Research Group, LM19.
  • Rezvani, K. (2013, February). UBXN2A Interferes with the p53-Mortalin2 Interaction in Cancer Cells and Constitutes a Potential Target for Cancer Therapy. Presented at the Ninth AACR-Japanese Cancer Association Joint Conference: Breakthroughs in Basic and Translational Cancer Research, Maui, HI .
  • Rezvani, K. (2012, July). Identification and Characterization of Multiple Distinct Proteasome Subpopulations in Brain Regions. Presented at the The 4th annual Ubiquitin Drug Discovery & Diagnostics Conference , Philadelphia .
  • Rezvani, K. (2012, June). UBXN2A interferes with the p53-Mortalin2 interactions in cancer cells and constitutes a potential target for cancer therapy. Presented at the Secound Symposium on Ubiquitin, Protein Quality Control, and Molecular Pathogenesis, Deadwood.
  • Rezvani, K., Starlight, J. (2011, July). Activation of p53 tumor suppressor by UBXN2A as a novel therapeutic approach in colon cancer. Presented at the 2nd Annual Student Research Symposium at Sanford Research/USD, Sioux fall .
  • Rezvani, K. (2011, June). UBXN2A Regulates p53 Localization and Stability through Interaction with Mortalin-2. Presented at the Inaugural Symposium on Ubiquitin, Protein Quality Control, and Molecular Pathogenesis, Vermillion.
  • Rezvani, K., Sane, S. (2011, April). Proteome-wide Profiling of Ubiquitinated and Sumoylated Substrates Targeted by UBX Containing Protein, UBXN2A. Presented at the 2011 IdeaFest, University of South Dakota.
  • Rezvani, K., Boudreau, D. (2011, April). UBXN2A Regulates p53 Localization and Stability through interaction with Mortalin2. Presented at the 2011 IdeaFest, University odf South Dakota.
  • Rezvani, K., Boudreau, D. (2011, February). UBXN2A Regulates p53 Localization and Stability through interaction with Mortalin2. Presented at the 2011 South Dakota Student Research Poster Session, Pierre, SD.